HCTZ Bottles Recalled After Discovery of Blood Thinner Tablet

Unichem Pharmaceuticals issued a voluntary nationwide recall of Hydrochlorothiazide 25mg tablets after the discovery of a Clopidogrel tablet in a bottle.

The precautionary recall is to avoid inappropriate treatment with Clopidogrel and experiencing side effects such as bleeding, bruising or hypersensitivity to the drug. The recall was also prompted to avoid missed doses of Hydrochlorothiazide, which could cause uncontrolled blood pressure and edema.

The affected products are packaged in 1000-count bottles. The bottles recalled are labeled with Lot# GHYL15028, expiration date April 2018, and were distributed May 21–28, 2015. Unichem is notifying its distributors and customers and is also arranging for return of all recalled products.

Clopidogrel is an antiplatelet agent indicated for patients at risk of atherosclerotic events. Hydrochlorothiazide is a diuretic indicated for hypertension and edema.